Interleukin-3 (IL-3, multi-CSF) is a growth factor for a variety of he
matopoietic progenitor cells. Recently, microglial cells, the resident
macrophages of the central nervous system (CNS) have been shown to pr
oliferate in the presence of IL-3 both in vivo and in culture. Data ob
tained from cultured astrocytes gave rise to the hypothesis that astro
cytes synthesize the microglial growth factor. This is the first repor
t identifying rat microglial cells themselves as a source of IL-3. Cul
ture media conditioned by isolated microglia enhanced microglial proli
feration above fresh media controls. IL-3 polypeptide was detected in
both conditioned media (CM) and in microglial cells by Western blottin
g and immunoprecipitation. Furthermore, anti-IL-3 antibodies were able
to inhibit microglial proliferation induced by conditioned media. mRN
A(IL-3) was present in single microglial cells as revealed by in situ
hybridization. Total RNA prepared from purified microglia yielded a si
ngle PCR amplification product. Identity of the PCR product was confir
med by Southern blot hybridization using a cDNA(IL-3) probe and by DNA
sequencing. Expression of mRNA(IL-3) was observed in both absence and
presence of lipopolysaccharide, a bacterial endotoxin, that commonly
induces expression of inflammatory cytokines and inhibits microglial p
roliferation. It is concluded that IL-3 expression in microglial cells
is an early marker of inflammatory events in the brain preceding the
expression of other cytokines and most likely ensuring the recruitment
of enhanced numbers of immunocompetent cells at sites of lesion. In t
he light of weak immune reactions in the brain, it is hypothesized tha
t the expression of a characteristic T cell feature in monocyte-derive
d microglia may be a partial compensation of T cell functions in brain
lesions.